ImportRefusal LogoImportRefusal

Wuzhou Shui Foo Cheung Pharmaceutical Corp., Ltd.

⚠️ Moderate Risk

FEI: 3002623862 • Wuzhou, Guangxi Province • CHINA

FEI

FEI Number

3002623862

📍

Location

Wuzhou, Guangxi Province

🇨🇳

Country

CHINA
🏢

Address

Grand Creak Chengan, , Wuzhou, Guangxi Province, China

Moderate Risk

FDA Import Risk Assessment

34.2
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
4
Unique Violations
9/24/2013
Latest Refusal
1/8/2004
Earliest Refusal

Score Breakdown

Violation Severity
68.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
3.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2231×

FALSE

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
9/24/2013
62UAL11DEXTROMETHORPHAN HYDROBROMIDE (ANTI-TUSSIVE/COLD)
16DIRECTIONS
New York District Office (NYK-DO)
9/24/2013
64HBL02GUAIFENESIN (EXPECTORANT)
16DIRECTIONS
New York District Office (NYK-DO)
1/8/2004
64HBK02GUAIFENESIN (EXPECTORANT)
118NOT LISTED
223FALSE
75UNAPPROVED
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Wuzhou Shui Foo Cheung Pharmaceutical Corp., Ltd.'s FDA import refusal history?

Wuzhou Shui Foo Cheung Pharmaceutical Corp., Ltd. (FEI: 3002623862) has 3 FDA import refusal record(s) in our database, spanning from 1/8/2004 to 9/24/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Wuzhou Shui Foo Cheung Pharmaceutical Corp., Ltd.'s FEI number is 3002623862.

What types of violations has Wuzhou Shui Foo Cheung Pharmaceutical Corp., Ltd. received?

Wuzhou Shui Foo Cheung Pharmaceutical Corp., Ltd. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Wuzhou Shui Foo Cheung Pharmaceutical Corp., Ltd. come from?

All FDA import refusal data for Wuzhou Shui Foo Cheung Pharmaceutical Corp., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.